Clinical Trial Update: REJOIN Trial for Older Breast Cancer Survivors [NA]

View source ↗

Summary

The REJOIN trial evaluating treatments for older breast cancer survivors has completed; the study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Breast Cancer Female | NA | Status: COMPLETED